Volume 95 Issue 12 | p. 13 | Concentrates
Issue Date: March 20, 2017

Takeda drug candidates go to new firm

Department: Business
Keywords: pharmaceuticals, Japan, spin-off, Takeda

Takeda Pharmaceutical will inject eight drug candidates into a new biotech venture, Scohia Pharma. Innovation Network Corp. of Japan, a venture capital fund partly financed by the Japanese government, will own about 70% of the venture; the rest will be held by Takeda and its subsidiary Medipal Holdings. The drug candidates are in the renal, metabolic, and cardiovascular areas. The partners expect the spin-off to conduct research more efficiently while benefiting from Takeda scientists’ input.

. . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society